Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;97(1):41-50.
doi: 10.1111/cbdd.13757. Epub 2020 Jul 26.

Anticancer and antileishmanial in vitro activity of gold(I) complexes with 1,3,4-oxadiazole-2(3H)-thione ligands derived from δ-D-gluconolactone

Andrés Villaseñor Espinosa  1 , Danilo de Souza Costa  1 , Luiza Guimarães Tunes  2 , Rubens L do Monte-Neto  2 , Richard Michael Grazul  1 , Mauro Vieira de Almeida  1 , Heveline Silva  3
Affiliations

Anticancer and antileishmanial in vitro activity of gold(I) complexes with 1,3,4-oxadiazole-2(3H)-thione ligands derived from δ-D-gluconolactone

Andrés Villaseñor Espinosa et al. Chem Biol Drug Des. 2021 Jan.

Abstract

Four gold(I) complexes conceived as anticancer agents were synthesized by reacting [Au(PEt3 )Cl] and [Au(PPh3 )Cl] with ligands derived from δ-d-gluconolactone. The ligands' structure was designed to combine desired biological properties previously reported for each group. Ligands were synthesized from δ-d-gluconolactone via ketal protection and hydrazide formation followed by cyclization with CS2 to produce the novel oxadiazolidine-2-thione 7 and 8. Increasing of the ligands' lipophilicity via ketal protection proved useful since all four gold(I) complexes showed anticancer and antileishmanial properties. The IC50 values are at low micromolar range, varying from 2 to 3 μm for the most active compounds. The free D-gluconate 1,3,4 oxadiazole-derived ligands were neither toxic nor presented anticancer or antileishmanial properties. Triethylphosphine-derived compounds 9 and 10 were more selective against B16-F10 melanoma cell line. Although similar in vitro antileishmanial activity was observed for the gold(I) precursors themselves and their derived complexes, the latter were three times less toxic for human THP-1 macrophage cell line; this result is attributed to an isomeric variation of the D-gluconate ligand and the oxadiazole portion, which was one of the key concepts behind this work. These findings should encourage further research on gold(I) complexes to develop novel compounds with potential application in cancer and leishmaniasis chemotherapy.

Keywords: antitumor; leishmania; metal; synthesis.

PubMed Disclaimer

References

REFERENCES

    1. Baenziger, N. C., Bennett, W. E., & Soborofe, D. M. (1976). Chloro(triphenylphosphine)gold(I). Acta Crystallographica Section B, 32(3), 962-963. https://doi.org/10.1107/S0567740876004330
    1. Chaves, J. D. S., Damasceno, J. L., Paula, M. C. F., de Oliveira, P. F., Azevedo, G. C., Matos, R. C., … de Almeida, M. V. (2015). Synthesis, characterization, cytotoxic and antitubercular activities of new gold(I) and gold(III) complexes containing ligands derived from carbohydrates. BioMetals, 28(5), 845-860. https://doi.org/10.1007/s10534-015-9870-8
    1. Chaves, J. D. S., Neumann, F., Francisco, T. M., Corrêa, C. C., Lopes, M. T. P., Silva, H., … de Almeida, M. V. (2014). Synthesis and cytotoxic activity of gold(I) complexes containing phosphines and 3-benzyl-1,3-thiazolidine-2-thione or 5-phenyl-1,3,4-oxadiazole-2-thione as ligands. Inorganica Chimica Acta, 414, 85-90. https://doi.org/10.1016/j.ica.2014.01.042
    1. Chaves, O. A., Jesus, C. S. H., Cruz, P. F., Sant'Anna, C. M. R., Brito, R. M. M., & Serpa, C. (2016). Evaluation by fluorescence, STD-NMR, docking and semi-empirical calculations of the o-NBA photo-acid interaction with BSA. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 169, 175-181. https://doi.org/10.1016/j.saa.2016.06.028
    1. da Silva Maia, P. I., Deflon, V. M., & Abram, U. (2014). Gold(III) complexes in medicinal chemistry. Future Medicinal Chemistry, 6(13), 1515-1536. https://doi.org/10.4155/fmc.14.87

Publication types

MeSH terms

LinkOut - more resources